Evaluation of Antibacterial Efficacy of Two Commercially Available Probiotics as Intracanal Medicament against : An Study.

Aim: This study was performed to evaluate the antibacterial efficacy of two commercially available probiotics (BIFILAC and VSL 3) as intracanal medicament against in endodontic therapy.

Materials And Methods: Microorganisms from commercially available probiotics (BIFILAC and VSL 3) were extracted via the manufacturer's recommendations and mixed by weight. About 30 microliters were then placed on sterile discs.